1
|
Liégeois JF, Deville M, Dilly S, Lamy C, Mangin F, Résimont M, Tarazi FI. New Pyridobenzoxazepine Derivatives Derived from 5-(4-Methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): Chemical Synthesis and Pharmacological Evaluation. J Med Chem 2012; 55:1572-82. [DOI: 10.1021/jm2013419] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Jean-François Liégeois
- Laboratory
of Medicinal Chemistry,
Drug Research Center, University of Liège, avenue de l’Hôpital 1 (B36), B-4000 Liège
1, Belgium
| | - Marine Deville
- Laboratory
of Medicinal Chemistry,
Drug Research Center, University of Liège, avenue de l’Hôpital 1 (B36), B-4000 Liège
1, Belgium
| | - Sébastien Dilly
- Laboratory
of Medicinal Chemistry,
Drug Research Center, University of Liège, avenue de l’Hôpital 1 (B36), B-4000 Liège
1, Belgium
| | - Cédric Lamy
- Laboratory
of Medicinal Chemistry,
Drug Research Center, University of Liège, avenue de l’Hôpital 1 (B36), B-4000 Liège
1, Belgium
| | - Floriane Mangin
- Laboratory
of Medicinal Chemistry,
Drug Research Center, University of Liège, avenue de l’Hôpital 1 (B36), B-4000 Liège
1, Belgium
| | - Mélissa Résimont
- Laboratory
of Medicinal Chemistry,
Drug Research Center, University of Liège, avenue de l’Hôpital 1 (B36), B-4000 Liège
1, Belgium
| | - Frank I. Tarazi
- Department of
Psychiatry and
Neuroscience Program, Harvard Medical School and McLean Hospital, Boston, Massachusetts, United States
| |
Collapse
|
2
|
Graulich A, Léonard M, Résimont M, Huang XP, Roth BL, Liégeois JF. Chemical Modifications on 4-Arylpiperazine-Ethyl Carboxamide Derivatives Differentially Modulate Affinity for 5-HT1A, D4.2, and α2A Receptors: Synthesis and In Vitro Radioligand Binding Studies. Aust J Chem 2010. [DOI: 10.1071/ch09353] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
A series of substituted 4-aryl-piperazine-ethyl heteroarylcarboxamides were prepared and tested in in vitro radioligand binding studies. The presence of a quinoxaline has a favourable impact in terms of serotonin 5-HT1A versus dopamine D4.2 receptor selectivity. Compounds with a 3-CF3 group at the distal phenyl ring are the most effective in terms of affinity and selectivity for 5-HT1A versus D4.2 receptors. A 4-phenyl-1,2,3,6-tetrahydropyridine in place of the corresponding 4-phenyl-piperazine side chain is also favourable not only for the affinity for 5-HT1A and D4.2 receptors but also in some cases for α
2A-adrenoceptors.
Collapse
|